Shelton Capital Management acquired a new position in Medidata Solutions, Inc. (NASDAQ:MDSO) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 4,277 shares of the company’s stock, valued at approximately $334,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Medidata Solutions by 10.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,186 shares of the company’s stock worth $171,000 after buying an additional 208 shares during the period. Miles Capital Inc. acquired a new position in shares of Medidata Solutions in the first quarter worth about $202,000. Parametrica Management Ltd acquired a new position in shares of Medidata Solutions in the second quarter worth about $216,000. Invictus RG acquired a new position in shares of Medidata Solutions in the first quarter worth about $233,000. Finally, GSA Capital Partners LLP acquired a new position in shares of Medidata Solutions in the second quarter worth about $260,000. 97.52% of the stock is currently owned by institutional investors.
In related news, COO Michael L. Capone sold 5,000 shares of Medidata Solutions stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $74.53, for a total transaction of $372,650.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 5.80% of the company’s stock.
Shares of Medidata Solutions, Inc. (MDSO) opened at 79.45 on Friday. The firm’s 50-day moving average is $76.33 and its 200-day moving average is $72.79. The firm has a market cap of $4.50 billion, a P/E ratio of 128.35 and a beta of 1.77. Medidata Solutions, Inc. has a 1-year low of $46.10 and a 1-year high of $85.92.
Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, topping the Zacks’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million during the quarter, compared to analyst estimates of $134.28 million. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The company’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.24 EPS. On average, analysts anticipate that Medidata Solutions, Inc. will post $1.29 EPS for the current fiscal year.
Several analysts recently commented on MDSO shares. SunTrust Banks, Inc. raised their price objective on shares of Medidata Solutions from $80.00 to $90.00 and gave the company a “buy” rating in a research report on Tuesday, June 27th. J P Morgan Chase & Co raised their price objective on shares of Medidata Solutions to $87.00 and gave the company an “overweight” rating in a research report on Tuesday, July 18th. Citigroup Inc. reaffirmed a “buy” rating and set a $94.00 price objective (up previously from $77.00) on shares of Medidata Solutions in a research report on Monday, July 10th. KeyCorp reaffirmed a “buy” rating and set a $86.00 price objective on shares of Medidata Solutions in a research report on Sunday, September 17th. Finally, Royal Bank Of Canada began coverage on shares of Medidata Solutions in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $82.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Medidata Solutions currently has an average rating of “Buy” and an average price target of $84.64.
Medidata Solutions Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.